hearOAE
Audiometer. 510(k) K231545, from Hearx SA (Pty) , Ltd. (Pretoria, ZA). Product code EWO, class 2.
As of Nov 17, 2026, K231545 is an FDA 510(k) held by Hearx SA (Pty) , Ltd., substantially equivalent on Oct 27, 2023 after 150 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Oct 27, 2023
- Review time: 150 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFhearOAE is intended to be used by hearing healthcare professionals in the audiologic evaluation and documentation of ear function and ear disorders using Transient Evoked Otoacoustic Emissions (TEOAEs) and Distortion Product Otoacoustic Emissions (DPOAEs). The target population for the hearOAE includes all ages.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- ILO292 Dp Echoport Plus Oae SystemK983350 · Otodynamics, Ltd. · Dec 11, 1998
Other EWO Clearances
The newest 510(k)s for the same product code; their median review was 178 days; see every EWO device- OtoNova/OtoNova ProK234095 · Otodynamics · Jun 21, 2024
- Otoport ProK240430 · Otodynamics, Ltd. · Mar 15, 2024
- Sentiero, AuDX, AuDX PRO, Sentiero Desktop, AuDX PRO Flex, Sentiero Advanced, NavPRO ONEK213345 · Path Medical GmbH · Jun 22, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 30, 2023
- Review panel
- Ear, Nose, Throat
- Regulation
- 21 CFR 874.1050
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files